237 related articles for article (PubMed ID: 8806979)
1. Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rat.
Navarro-Cid J; Maeso R; Perez-Vizcaino F; Casal MC; Cachofeiro V; Ruilope LM; Tamargo J; Lahera V
Am J Hypertens; 1996 Jul; 9(7):669-74. PubMed ID: 8806979
[TBL] [Abstract][Full Text] [Related]
2. Quinapril treatment restores the vasodilator action of insulin in fructose-hypertensive rats.
Uchida T; Okumura K; Ito T; Kamiya H; Nishimoto Y; Yamada M; Tomida T; Matsui H; Hayakawa T
Clin Exp Pharmacol Physiol; 2002; 29(5-6):381-5. PubMed ID: 12010179
[TBL] [Abstract][Full Text] [Related]
3. Renal and vascular consequences of the chronic nitric oxide synthase inhibition. Effects of antihypertensive drugs.
Navarro-Cid J; Maeso R; Rodrigo E; Muñoz-García R; Ruilope LM; Lahera V; Cachofeiro V
Am J Hypertens; 1996 Nov; 9(11):1077-83. PubMed ID: 8931832
[TBL] [Abstract][Full Text] [Related]
4. Effects of losartan on blood pressure, metabolic alterations, and vascular reactivity in the fructose-induced hypertensive rat.
Navarro-Cid J; Maeso R; Perez-Vizcaino F; Cachofeiro V; Ruilope LM; Tamargo J; Lahera V
Hypertension; 1995 Dec; 26(6 Pt 2):1074-8. PubMed ID: 7498971
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
Cabezas-Cerrato J; Garcia-Estevez DA; Araújo D; Iglesias M
Metabolism; 1997 Feb; 46(2):173-8. PubMed ID: 9030825
[TBL] [Abstract][Full Text] [Related]
6. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance.
Anuradha CV; Balakrishnan SD
Can J Physiol Pharmacol; 1999 Oct; 77(10):749-54. PubMed ID: 10588478
[TBL] [Abstract][Full Text] [Related]
7. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension. Swedish Quinapril Group.
Ostman J; Asplund K; Bystedt T; Dahlöf B; Jern S; Kjellström T; Lithell H
J Intern Med; 1998 Aug; 244(2):95-107. PubMed ID: 10095796
[TBL] [Abstract][Full Text] [Related]
8. The effects of an angiotensin-converting enzyme inhibitor and an angiotensin II receptor antagonist on insulin resistance in fructose-fed rats.
Higashiura K; Ura N; Takada T; Li Y; Torii T; Togashi N; Takada M; Takizawa H; Shimamoto K
Am J Hypertens; 2000 Mar; 13(3):290-7. PubMed ID: 10777034
[TBL] [Abstract][Full Text] [Related]
9. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
[TBL] [Abstract][Full Text] [Related]
10. Quinapril reduces microalbuminuria in essential hypertensive and in diabetic hypertensive subjects.
Dominguez LJ; Barbagallo M; Kattah W; Garcia D; Sowers JR
Am J Hypertens; 1995 Aug; 8(8):808-14. PubMed ID: 7576397
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of blood pressure reduction from end-organ damage in TGR(mREN2)27 transgenic hypertensive rats.
Teisman AC; Pinto YM; Buikema H; Flesch M; Böhm M; Paul M; van Gilst WH
J Hypertens; 1998 Dec; 16(12 Pt 1):1759-65. PubMed ID: 9869009
[TBL] [Abstract][Full Text] [Related]
12. Effects of quinapril and losartan on insulin sensitivity in genetic hypertensive rats with different metabolic abnormalities.
Nakagawa H; Daihara M; Tamakawa H; Nozue T; Kawahara K
J Cardiovasc Pharmacol; 1999 Jul; 34(1):28-33. PubMed ID: 10413063
[TBL] [Abstract][Full Text] [Related]
13. Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.
Arvola P; Ruskoaho H; Wuorela H; Pekki A; Vapaatalo H; Pörsti I
Br J Pharmacol; 1993 Apr; 108(4):980-90. PubMed ID: 8485636
[TBL] [Abstract][Full Text] [Related]
14. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue.
Giacchetti G; Sechi LA; Griffin CA; Don BR; Mantero F; Schambelan M
J Hypertens; 2000 Jun; 18(6):695-702. PubMed ID: 10872553
[TBL] [Abstract][Full Text] [Related]
15. Effects of L-arginine on blood pressure and metabolic changes in fructose-hypertensive rats.
Tay A; Ozçelikay AT; Altan VM
Am J Hypertens; 2002 Jan; 15(1 Pt 1):72-7. PubMed ID: 11824864
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension.
Thöne-Reineke C; Olivier J; Godes M; Zart R; George I; Bauer C; Neumayer HH; Hocher B
Clin Sci (Lond); 2003 Jan; 104(1):79-85. PubMed ID: 12519090
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms of insulin resistance in rats with fructose-induced hypertension.
Catena C; Giacchetti G; Novello M; Colussi G; Cavarape A; Sechi LA
Am J Hypertens; 2003 Nov; 16(11 Pt 1):973-8. PubMed ID: 14573337
[TBL] [Abstract][Full Text] [Related]
18. Quinapril and blood lipids.
Koskinen P; Manninen V; Eisalo A
Br J Clin Pharmacol; 1988 Oct; 26(4):478-80. PubMed ID: 3190999
[TBL] [Abstract][Full Text] [Related]
19. Alteration of muscle fiber composition linking to insulin resistance and hypertension in fructose-fed rats.
Higashiura K; Ura N; Takada T; Agata J; Yoshida H; Miyazaki Y; Shimamoto K
Am J Hypertens; 1999 Jun; 12(6):596-602. PubMed ID: 10371369
[TBL] [Abstract][Full Text] [Related]
20. Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
Blanco S; Penin R; Casas I; López D; Romero R
Kidney Int Suppl; 2002 Dec; (82):S27-31. PubMed ID: 12410851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]